[HTML][HTML] Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells

AR Poh, RJJ O'Donoghue, M Ernst - Oncotarget, 2015 - ncbi.nlm.nih.gov
The hematopoietic cell kinase (HCK) is a member of the SRC family of cytoplasmic tyrosine
kinases (SFKs), and is expressed in cells of the myeloid and B-lymphocyte cell lineages …

Phosphorylation of unique domains of Src family kinases

I Amata, M Maffei, M Pons - Frontiers in genetics, 2014 - frontiersin.org
Members of the Src family of kinases (SFKs) are non-receptor tyrosine kinases involved in
numerous signal transduction pathways. The catalytic, SH3 and SH2 domains are attached …

Saracatinib inhibits middle east respiratory syndrome-coronavirus replication in vitro

JS Shin, E Jung, M Kim, RS Baric, YY Go - Viruses, 2018 - mdpi.com
The Middle East respiratory syndrome-coronavirus (MERS-CoV), first identified in Saudi
Arabia, is an emerging zoonotic pathogen that causes severe acute respiratory illness in …

HIV-1 reprograms the migration of macrophages

C Vérollet, S Souriant, E Bonnaud… - Blood, The Journal …, 2015 - ashpublications.org
Macrophages are motile leukocytes, targeted by HIV-1, thought to play a critical role in host
dissemination of the virus. However, whether infection impacts their migration capacity …

A facile method for preparation and evaluation of the antimicrobial efficiency of various heterocycles containing thieno[2,3-d]pyrimidine

AF Saber, M Sayed, MS Tolba… - Synthetic …, 2021 - Taylor & Francis
Heterocyclic compounds play an important role in the field of pharmaceutical chemistry,
especially compounds containing hybrid bioactive moieties. So in continuation of our work …

Hematopoietic cell kinase (HCK) is a player of the crosstalk between hematopoietic cells and bone marrow niche through CXCL12/CXCR4 axis

FM Roversi, MLP Bueno, FV Pericole… - Frontiers in cell and …, 2021 - frontiersin.org
The crosstalk between hematopoietic stem/progenitor cells (HSC), both normal and
leukemic, and their neighboring bone marrow (BM) microenvironment (niche) creates a …

[HTML][HTML] Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and …

FM Roversi, FV Pericole, JA Machado-Neto… - … et Biophysica Acta (BBA …, 2017 - Elsevier
New drug development for neoplasm treatment is nowadays based on molecular targets that
participate in the disease pathogenesis and tumor phenotype. Herein, we describe a new …

Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia

FM Roversi, MLP Bueno, JAF da Silva… - Cancer Immunology …, 2022 - Springer
Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are characterized by
risk of relapses, poor survival, unwanted side effects and high toxicity with the current …

Identification of a new family of pyrazolo [3, 4-d] pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B-and T-lymphoma cell lines

AL Fallacara, R Passannanti, M Mori, G Iovenitti… - European journal of …, 2019 - Elsevier
Abnormal activation of B-cell receptor (BCR) signaling plays a key role in the development
of lymphoid malignancies, and could be reverted by the simultaneous inhibition of Lyn, Fyn …

Pyridin-2 (1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

J Lin, A Ericsson, AM Campbell, G Gustafson… - US Patent …, 2018 - Google Patents
US10005734B2 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate
dehydrogenase inhibitors - Google Patents US10005734B2 - Pyridin-2(1H)-one …